RPLM

Latest SEC Filings & News for RPLM

1 most recent filing and news item mentioning RPLM. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/RPLM/news?limit=20"

Pull RPLM filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJul 30, 2026Neutral

Replimune submits RP1/Opdivo BLA for melanoma

Replimune Group filed a Biologics License Application for RP1 combined with nivolumab to treat advanced cutaneous melanoma following anti-PD-1 failure. The filing relies on a single-arm pivotal trial and comes amid key alignments and accumulating clinical data.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.